Press release
What Driving The Nasal Spray Market | Top Key Playes - ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc., ARIUS FORMULATIONS PVT LTD., Renatus, Bayer AG, J Pharmaceuticals, Aurena, Cipla Inc., INNOVUS PHARMACEUTICALS, INC., Sandoz International
Nasal Spray Market Size, Share and Global Trend By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings), and Geography Forecast till 2026.Get Sample Copy Of Lymphoma Treatment Market Report at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-spray-market-100273
The global nasal sprays market is slated to witness accelerated growth with increasing regulatory approvals for newer products. According to a report by Fortune Business Insights, titled "Nasal Spray Market Size, Share and Global Trend By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings) Geography Forecast till 2026," the market is likely to surge in the coming years with encouragement from increasing FDA approval of newer products.
FDA Approves Janssen's nasal spray 'Spravato'
In March 2019, the US Food and Drug Administration (USFDA) passed a usage approval for "Spravato". Janssen's Spravato was a fast processing antidepressant drug. The approval has encouraged Janssen's counterparts and many have been encouraged to introduce newer products. Spravato was a product with high efficacy and much reduced side effects. The approval for Spravato will have a positive impact on the global market and is likely to favor the growth of the market in the coming years.
Increasing Incidence of Allergic Rhinitis to Lead to Increased Demand
According to the Australian Institute of Health and Welfare, in 2014, around 4.5 million people suffered from allergic rhinitis in Australia. Certain indications of allergic rhinitis such as fever, cold and bad breath can be overcome using nasal sprays. A high prevalence of nasal disorders and allergies is likely to cause an increased adoption of nasal sprays, globally. The increased adoption may have a positive impact on the global market and are likely to favor growth of the market in the coming years. As per a study by the Food and Drug Administration (FDA), in 2018, around 7.4 million adults in the U.S suffer from treatment-resistant depression. Increasing prevalence of this disorder may lead to increased chances of suicidal tendencies and hospitalization. Increasing hospitalization may lead to further demand for nasal sprays and thereby, enable growth of the global nasal sprays market in the forthcoming years.
Painless drug delivery modes are a major factor that may favor the growth of the global nasal sprays market. Additionally, ease of availability and improved patient convenience are other factors that may boost the market in coming years. Having said that, certain adverse reactions of nasal spray and side effects such as nasal dryness, congestion and inflammation may hamper the growth of the global nasal sprays market in the coming years.
Some of the leading companies that are present in the global nasal spray market are ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc., ARIUS FORMULATIONS PVT LTD., Renatus, Bayer AG, J Pharmaceuticals, Aurena, Cipla Inc., INNOVUS PHARMACEUTICALS, INC., Sandoz International GmbH, Leeford Healthcare Limited, ALLERGAN, Sunovion Pharmaceuticals Inc., Nephron Pharmaceuticals Corporation, Mylan N.V., and others.
Browse complete report at: https://www.fortunebusinessinsights.com/industry-reports/nasal-spray-market-100273
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights Pvt. Ltd.
Supreme Headquarters,
Pune Banglore Highway, Baner, Pune,
Maharashtra 411045, India
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Driving The Nasal Spray Market | Top Key Playes - ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc., ARIUS FORMULATIONS PVT LTD., Renatus, Bayer AG, J Pharmaceuticals, Aurena, Cipla Inc., INNOVUS PHARMACEUTICALS, INC., Sandoz International here
News-ID: 1987932 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Spravato
Spravato Treatment in Folsom, CA: Safe, Effective Depression Relief Now Offered …
Grace Mental Health Resources, INC, a leading outpatient mental health clinic in Folsom, California, is now offering Spravato® (esketamine) treatment for adults struggling with treatment-resistant depression (TRD). Led by board-certified psychiatric mental health nurse practitioner Julie Bergman, PMHNP, the clinic provides a safe, structured, and supportive environment for patients to explore new pathways to mental wellness through FDA-approved treatments.
Spravato® is a breakthrough medication developed specifically for individuals who have not…
The Mood Wellness Center Opens New Location in Columbia, Maryland, to Offer Adva …
The Mood Wellness Center announces the grand opening of its Columbia, MD, location, expanding its advanced mental health and chronic pain treatments. The center offers innovative therapies, including ketamine IV infusions, SPRAVATO Registered , TMS, and vitamin IV therapy, targeting conditions like depression, anxiety, PTSD, and chronic pain. With over 50 years of expertise, The Mood Wellness Center provides cutting-edge, patient-focused care for those seeking alternative solutions.
Columbia, MD - February…
Englewood Wellness Associates Announces Life-Changing Mental Health Services
Image: https://www.getnews.info/wp-content/uploads/2024/08/1723125924.jpeg
In a recent public service announcement, Balanced Mental Wellness shared the solutions to modern mental health obstacles.
Englewood, CO - Englewood Wellness Associates offers innovative and integrative treatment options for individuals in Englewood and Littleton, Colorado. Balanced Mental Wellness provides timely and effective care for those experiencing various mental health conditions, including depression, anxiety, PTSD, and more.
Balanced Mental Wellness offers same-day appointments and no wait lists for medication management,…
SPRAVATO for Major Depressive Disorder: Market Size and Share Analysis and Compe …
DelveInsight has released a comprehensive report titled "SPRAVATO Market Forecast" offering a thorough examination and predictive insights into the SPRAVATO market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The extensive report offers a thorough examination of the market potential and market share of SPRAVATO in the therapeutics landscape for Major Depressive Disorder across the…
Global Depression Treatment Market Share 2021: Global Trends, Key Players, Indus …
The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period (2020-2027). The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players are certain factors driving the growth of the depression treatment industry.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/depression-treatment-market
In February 2021, Zydus Cadila has received US FDA approval…
Nasal Spray Market 2020 Growth Projection by Leading Players: ADAPT Pharma, Inc. …
Report analyzes Global Nasal Spray Market Growth Information By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings), and Region.
To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-spray-market-100273
Nasal Spray Key Players Market Studied In Report:
ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc.,…
